TTR vs. AL cardiac amyloidosis: Don't rely on imaging alone

TTR vs. AL cardiac amyloidosis: Don't rely on imaging alone

Mayo Clinic cardiologists Martha Grogan, M.D., and Omar F. Abou Ezzeddine, M.D., C.M., M.S., discuss transthyretin (TTR) amyloidosis and AL amyloidosis.

General characteristics of cardiac amyloidosis can include unexplained heart failure, unexplained atrial fibrillation, and physical exam findings such as jugular venous pressure elevation, lower extremity edema, and abdominal distension. Diagnosis and treatment of amyloidosis vary depending on the type. Patients with amyloidosis can deteriorate rapidly, so diagnosing quickly is very important.

This video first appeared on theheart.org | Medscape Cardiology.

|


Published

July 8, 2019

Created by

Mayo Clinic